Diamyd Medical is a diabetes company headquartered in Stockholm, Sweden. The Company develops the diabetes vaccine Diamyd® with the active ingredient GAD, which has the potential to become a key piece of the puzzle of a future solution to prevent, treat or cure type 1 diabetes and other forms of diabetes.
Inspelat vid Diamyds Frukostseminarium i Stockholm. Doktor Helena Elding-Larsson berättar om den spännande oberoende studien DiAPREV-IT med diabetesva...